MedTrace Logo

Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up

NCT04688593 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 520

Last updated 2024-01-25

No results posted yet for this study

Summary

The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results.

The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.

Conditions

  • Osteoarthritis, Hip
  • Hip Osteoarthritis
  • Prosthesis Survival
  • Prosthesis Failure

Interventions

DEVICE

MobileLink

Patients who receive a MobileLink hip prosthesis system will be followed-up for 10 years.

Sponsors & Collaborators

  • Waldemar Link GmbH & Co. KG

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-04
Primary Completion
2036-01-31
Completion
2036-01-31
FDA Device
Yes

Countries

  • Germany
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04688593 on ClinicalTrials.gov